Idéal Investisseur
Français English
CAC 40 : Market closed
8 218,24 pts
-0.32%


Last updated : 05/06/2026 - 17h29 (last close)
Last close data
🏠 Home   ➤    Stock news

Inventiva's Stock Rises 5.56% Mid-Day Amid Weakness in the CAC 40

Inventiva stands out from the general apathy of the French market. The stock is up 5.56% mid-day while the CAC 40 is down 0.51%. This divergence reflects a distinct momentum for the biotech, driven by solid quarterly performances accumulated over several months.


Inventiva's Stock Rises 5.56% Mid-Day Amid Weakness in the CAC 40

Inventiva's Current Trading Position

Inventiva is trading at €3.79 mid-day, up 5.56% from the previous close of €3.60. This increase contrasts with the general weakness of the French market: over the same period, the CAC 40 has fallen by 0.51% to 8,032.68 points. The extent of this decorrelation highlights a particular dynamic of the biotech stock. In terms of volume, the share of capital traded reaches 0.2%, indicating limited activity despite the price increase. In the longer term, Inventiva has shown remarkable performance: over three months, the stock has increased by 34.81%, and over one year, the increase reaches 57.47%, compared to 8.45% for the CAC 40 over the same annual period.

Recent Developments at Inventiva

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Inventiva has undergone several significant changes in the past two months. At the end of September, the laboratory published its results for the first half of 2025, showing increased losses compared to the previous year. On October 1st, Andrew Obenshain took over as CEO, succeeding co-founder Frédéric Cren. In October, the group launched a new At-The-Market (ATM) program, enhancing its financing capacity. The laboratory also presented several communications at the AASLD The Liver Meeting in October, a major event in the hepatology sector. Furthermore, the group's financing covers its needs until the end of the third quarter of 2026.

Technical Perspective on Inventiva's Stock

From a technical standpoint, the stock is fluctuating between its 50-day moving average at €4.25 and its 200-day moving average at €3.21, confirming a structural upward trend. The RSI is at 51, indicating a balance between buying and selling pressures. The Bollinger Bands place the price near their median envelope, with support at €2.90 and resistance at €4.15. However, the stochastic generates a sell signal, tempering the day's optimism. The major technical resistance threshold is at €5.34.



Sector Santé · Biotechnologies · Vaccins et laboratoires de recherche Biotechnologie


Assurance vie

Context

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 0€
Risks mentioned
  • Aucune garantie que les bons de souscription seront exercés en totalité.
  • Inventiva a un historique d'exploitation limité et a subi des pertes importantes.
Opportunities identified
  • Estime que sa trésorerie lui permettra de financer ses activités jusqu'à la mi-premier trimestre 2027.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit